|
|
Blood, 1 December 2005, Vol. 106, No. 12, pp. 3970-3978.
Prepublished online as a Blood First Edition Paper on August 11, 2005; DOI 10.1182/blood-2005-03-1292.
Previous Article | Next Article 
Submitted March 30, 2005
Accepted July 28, 2005
The mechanism and impact of thrombospondin-4 polymorphisms on neutrophil function
Elzbieta Pluskota, Olga I Stenina, Irene Krukovets, Dorota Szpak, Eric J Topol, and Edward F Plow*
Joseph Jacobs Center for Thrombosis and Vascular Biology, Cleveland Clinic Foundation, Cleveland, OH, USA
* Corresponding author; email: plowe{at}ccf.org.
High-throughput genomic technology identified an association between a single nucleotide polymorphism (SNP), a proline (P387) rather than the predominant alanine (A387) at position 387 in thrombospondin-4 (TSP-4), and premature myocardial infarction. The inflammatory hypothesis of atherosclerosis invokes a prominent role of leukocytes and cytokines in pathogenesis. As the expression of TSP-4 by vascular cells permits its exposure to circulating leukocytes, the interactions of human neutrophils (PMN) with both TSP-4 variants were investigated. PMA-stimulated PMNs adhered and migrated well and equally on the TSP-4 variants. Integrin M 2 was identified as the TSP-4 receptor mediating these responses and the 3 EGF-like domains of TSP-4 harboring the SNPs interacted with the MI-domain. Despite the similarity in these responses, the P387 variant induced more robust tyrosine phosphorylation of the stress-related MAPKs: p38MAPK and JNK, as well as STAT1 and HSP27 than the A387 variant. Additionally, cells adherent to P387 TSP-4 variant released 4-fold more H2O2 and secreted 2-fold more IL-8 as compared to the A387. H2O2 release and p38MAPK activation were totally inhibited by blockade of M 2. Thus, M 2 plays a central role in proinflammatory activities of TSP-4 (P387) and may contribute to the prothrombotic phenotype associated with this variant.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Pluskota, N. M. Woody, D. Szpak, C. M. Ballantyne, D. A. Soloviev, D. I. Simon, and E. F. Plow
Expression, activation, and function of integrin {alpha}M{beta}2 (Mac-1) on neutrophil-derived microparticles
Blood,
September 15, 2008;
112(6):
2327 - 2335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Koch, P. Hoppmann, A. de Waha, A. Schomig, and A. Kastrati
Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence
Hum. Mol. Genet.,
April 15, 2008;
17(8):
1120 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Caceres, C. Suwyn, M. Maddox, J. W. Thomas, and T. M. Preuss
Increased Cortical Expression of Two Synaptogenic Thrombospondins in Human Brain Evolution
Cereb Cortex,
October 1, 2007;
17(10):
2312 - 2321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. I. Stenina, E. J. Topol, and E. F. Plow
Thrombospondins, Their Polymorphisms, and Cardiovascular Disease
Arterioscler Thromb Vasc Biol,
September 1, 2007;
27(9):
1886 - 1894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Topol, J. Smith, E. F. Plow, and Q. K. Wang
Genetic susceptibility to myocardial infarction and coronary artery disease
Hum. Mol. Genet.,
October 15, 2006;
15(suppl_2):
R117 - R123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|